We are live on ! Find out more
CRL icon

Charles River Laboratories

633 hedge funds and large institutions have $12.4B invested in Charles River Laboratories in 2023 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 204 increasing their positions, 258 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more funds holding in top 10

Funds holding in top 10: 38 (+5)

34% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 70

22% more capital invested

Capital invested by funds: $10.1B → $12.4B (+$2.25B)

2% more funds holding

Funds holding: 621633 (+12)

1.21% more ownership

Funds ownership: 101.05%102.25% (+1.2%)

21% less repeat investments, than reductions

Existing positions increased: 204 | Existing positions reduced: 258

32% less call options, than puts

Call options by funds: $54.7M | Put options by funds: $80.5M

Holders
633
Holders Change
+12
Holders Change %
+1.93%
% of All Funds
9.23%
Holding in Top 10
8
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+166.67%
% of All Funds
0.12%
New
94
Increased
204
Reduced
258
Closed
70
Calls
$54.7M
Puts
$80.5M
Net Calls
-$25.8M
Net Calls Change
-$3.78M
Name Holding Trade Value Shares
Change
Change in
Stake
BCIM
126
British Columbia Investment Management
British Columbia, Canada
$12M +$249K +1,267 +3%
CCM
127
Channing Capital Management
Illinois
$12M +$237K +1,205 +2%
CS
128
Credit Suisse
Switzerland
$11.3M -$171K -869 -2%
Public Employees Retirement Association of Colorado
129
Public Employees Retirement Association of Colorado
Colorado
$11.2M -$79.1K -402 -0.8%
Mitsubishi UFJ Asset Management
130
Mitsubishi UFJ Asset Management
Japan
$11.1M -$14.2K -72 -0.1%
Bank of Montreal
131
Bank of Montreal
Ontario, Canada
$11M +$2.15M +10,937 +31%
BNP Paribas Financial Markets
132
BNP Paribas Financial Markets
France
$10.9M -$283K -1,437 -3%
OAM
133
Oppenheimer Asset Management
New York
$10.5M -$726K -3,690 -8%
Janney Montgomery Scott
134
Janney Montgomery Scott
Pennsylvania
$10.3M -$241K -1,225 -3%
BCM
135
Bridgeway Capital Management
Texas
$10.3M -$344K -1,750 -4%
BAM
136
Bell Asset Management
Australia
$10.3M -$1.35M -6,868 -14%
Northwestern Mutual Wealth Management
137
Northwestern Mutual Wealth Management
Wisconsin
$9.95M +$555K +2,821 +7%
HFS
138
Hantz Financial Services
Michigan
$9.91M -$631K -3,208 -7%
Truist Financial
139
Truist Financial
North Carolina
$9.68M -$218K -1,106 -3%
LPL Financial
140
LPL Financial
California
$9.62M +$458K +2,329 +6%
CWM
141
Curi Wealth Management
North Carolina
$9.46M -$1.71M -8,699 -18%
ECM
142
ExodusPoint Capital Management
New York
$9.18M -$5.17M -26,296 -40%
JPMIA
143
J.P. Marvel Investment Advisors
Massachusetts
$9.17M -$4.92K -25 -0.1%
NIG
144
NFJ Investment Group
Texas
$9.11M -$1.33M -6,779 -15%
RPAM
145
Rhenman & Partners Asset Management
Sweden
$8.98M -$1.18M -6,000 -14%
Prudential Financial
146
Prudential Financial
New Jersey
$8.89M -$1.38M -7,000 -15%
NGM
147
North Growth Management
British Columbia, Canada
$8.76M
AC
148
Armistice Capital
New York
$8.51M -$23.6M -120,000 -77%
SO
149
STRS Ohio
Ohio
$8.26M +$268K +1,363 +4%
APG Asset Management
150
APG Asset Management
Netherlands
$8.24M -$536K -2,726 -7%

CRL Hedge Fund Activity: Q4 2023 in Review

633 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2023, worth a combined $12.4B — up 22% from $10.1B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new CRL positions and 70 closed out — a net gain of 24 holders — while 204 added to existing stakes and 258 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $82.4M. The largest seller was Fidelity Investments, cutting an estimated $103M.

  • 633 institutional investors held Charles River Laboratories (CRL) as of Q4 2023, up from 621 in Q3 2023.
  • Funds reported $12.4B of Charles River Laboratories stock for Q4 2023, up 22% quarter-over-quarter.
  • 94 funds opened new Charles River Laboratories positions in Q4 2023 and 70 closed out, a net change of +24 holders.
  • The largest Charles River Laboratories buyer in Q4 2023 was Morgan Stanley, an estimated $82.4M added.
  • The largest Charles River Laboratories seller in Q4 2023 was Fidelity Investments, an estimated $103M sold.

Based on aggregated 13F filings for Q4 2023.